TSH-RECEPTOR ANTIBODIES IN MOTHERS WITH GRAVES' DISEASE AND OUTCOME IN THEIR OFFSPRING
- 1 January 1988
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 331 (8575-8576) , 14-17
- https://doi.org/10.1016/s0140-6736(88)91001-x
Abstract
No abstract availableFunding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 17 references indexed in Scilit:
- Thyroid-stimulating immunoglobulins and thyroid function tests in two siblings with neonatal thyrotoxicosisEuropean Journal of Pediatrics, 1986
- Paired determination of thyroid-stimulating and TSH-binding inhibitory activities in patients with Graves' disease during antithyroid drug treatmentActa Endocrinologica, 1986
- FETAL HYPERTHYROIDISM: EXPERIENCE OF TREATMENT IN FOUR SIBLINGSThe Lancet, 1985
- A RECEPTOR ASSAY FOR THE MEASUREMENT OF TSH RECEPTOR ANTIBODIES IN UNEXTRACTED SERUMClinical Endocrinology, 1984
- Neonatal transient thyrotoxicosis resulting from maternal TSH-binding inhibitor immunoglobulinsThe Journal of Pediatrics, 1983
- Multicomponent structure of the thyrotropin receptor: Relationship to Graves' diseaseLife Sciences, 1983
- Neonatal Thyroid Function after Propylthiouracil Therapy for Maternal Graves' DiseaseNew England Journal of Medicine, 1981
- THE ROLE OF THYROID STIMULATING IMMUNOGLOBULINS OF GRAVES'S DISEASE IN NEONATAL THYROTOXICOSISBJOG: An International Journal of Obstetrics and Gynaecology, 1978
- Neonatal Hyperthyroidism and Long-acting Thyroid Stimulator ProtectorBMJ, 1974
- THYROID-STIMULATING IMMUNOGLOBULINS IN GRAVES' DISEASEThe Lancet, 1974